Pretreatment with darbepoetin attenuates renal injury in a rat model of cisplatin-induced nephrotoxicity

Korean Journal of Internal Medicine

Volumn 24, Issue 3, 2009, Pages 238-246

  Choi, Dae Eun ^a   Jeong, Jin Young ^a   Lim, Beom Jin ^a   Lee, Kang Wook ^a   Shin, Young Tai ^a   Na, Ki Ryang ^a  

^a Chungnam National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cisplatin; Darbepoetin alfa; Inflammation

Indexed keywords

CASPASE 3; CISPLATIN; FAS ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UREA; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HEMATOCRIT; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; APOPTOSIS; DRUG EFFECT; KIDNEY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; ERYTHROPOIETIN; HEMATOCRIT; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70449719330     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.3.238     Document Type: Article

References (29)

1. Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 1986; 8:368-379. (Pubitemid 17235084)
2. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334:115-124.
3. Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007;230: 64-75. (Pubitemid 46084872)
4. Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007;230:256-264. (Pubitemid 46109145)
5. Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Toxicology 1989;59:151-162.
6. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 2005;212:116-123. (Pubitemid 40981968)
7. Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999;19:643-651. (Pubitemid 30161216)
8. Abdelrahman M, Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004;22:63-69. (Pubitemid 40228212)
9. Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 2004;63:208-216.
10. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004;19:348-355. (Pubitemid 38195983)
11. Bagnis C, Beaufils H, Jacquiaud C, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 2001;16:932-938. (Pubitemid 32440364)
12. Lee SH, Li C, Lim SW, et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol 2005;25:64-76. (Pubitemid 40529278)
13. Macdougall IC. Novel erythropoiesis stimulating protein. Semin Nephrol 2000;20:375-381.
14. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006;69:1806-1813. (Pubitemid 43739209)
15. Tsuruya K, Ninomiya T, Tokumoto M, et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003;63:72-82. (Pubitemid 35463908)
16. Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat 2005;8:5-14. (Pubitemid 40797952)
17. Zhang B, Ramesh G, Norbury CC, Reeves WB. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 2007;72:37-44. (Pubitemid 47014442)
18. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. Inhibitory effects of aqueous crude extract of Saffron (Crocus sativus L.) on chemical-induced genotoxicity in mice. Asia Pac J Clin Nutr 2003;12:474-476. (Pubitemid 38886967)
19. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110:835-842. (Pubitemid 35050961)
20. Locatelli F, Vecchio LD. Darbepoetin alfa: amgen. Curr Opin Investig Drugs 2001;2:1097-1104.
21. Smith RE Jr, Jaiyesimi IA, Meza LA, et al. Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer 2001;84(Suppl 1):24-30. (Pubitemid 32453432)
22. Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003;17:1754-1755.
23. Sharples EJ, Patel N, Brown P, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemiareperfusion. J Am Soc Nephrol 2004;15:2115-2124. (Pubitemid 39031350)
24. Gao E, Boucher M, Chuprun JK, Zhou RH, Eckhart AD, Koch WJ. Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart. Am J Physiol Heart Circ Physiol 2007;293:H60-H68.
25. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003;198: 971-975. (Pubitemid 37152934)
26. Agnello D, Bigini P, Villa P, et al. Erythropoietin exerts an antiinflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002;952:128-134. (Pubitemid 35279495)
27. Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK. Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int 2004;65:452-458. (Pubitemid 38130639)
28. Vaziri ND, Zhou XJ, Liao SY. Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol 1994; 266:F360-F366. (Pubitemid 24115761)
29. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial 2003;16:245-256.